Urinary N-telopeptide as a Biomarker of Disease Activity in Patients with Chronic Nonbacterial Osteomyelitis Who Have Not Received Bisphosphonates

University of Washington School of Medicine, Seattle, Washington; Seattle Children’s Hospital, Seattle, Washington, and Janssen Research & Development, LLC, Spring House, Pennsylvania; University of Iowa Carver College of Medicine, Iowa City, Iowa; Seattle Children’s Hospital and Clinical and Translational Research Center, Seattle, Washington, USA. This study is supported by The Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Arthritis Foundation Small Grants program, and the Chronic Recurrent Multifocal Osteomyelitis (CRMO) Research Fund at the University of Iowa. PJF is supported by R01 AR059703 and by the Marjorie K. Lamb Professorship. YZ received research support from CARRA and Bristol-Myers Squibb. Address correspondence to Dr. Y. Zhao4, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Email: yongdong.zhao@seattlechildrens.org.

University of Washington School of Medicine, Seattle, Washington; Seattle Children’s Hospital, Seattle, Washington, and Janssen Research & Development, LLC, Spring House, Pennsylvania; University of Iowa Carver College of Medicine, Iowa City, Iowa; Seattle Children’s Hospital and Clinical and Translational Research Center, Seattle, Washington, USA. This study is supported by The Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Arthritis Foundation Small Grants program, and the Chronic Recurrent Multifocal Osteomyelitis (CRMO) Research Fund at the University of Iowa. PJF is supported by R01 AR059703 and by the Marjorie K. Lamb Professorship. YZ received research support from CARRA and Bristol-Myers Squibb. Address correspondence to Dr. Y. Zhao4, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Email: yongdong.zhao@seattlechildrens.org.

University of Washington School of Medicine, Seattle, Washington; Seattle Children’s Hospital, Seattle, Washington, and Janssen Research & Development, LLC, Spring House, Pennsylvania; University of Iowa Carver College of Medicine, Iowa City, Iowa; Seattle Children’s Hospital and Clinical and Translational Research Center, Seattle, Washington, USA. This study is supported by The Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Arthritis Foundation Small Grants program, and the Chronic Recurrent Multifocal Osteomyelitis (CRMO) Research Fund at the University of Iowa. PJF is supported by R01 AR059703 and by the Marjorie K. Lamb Professorship. YZ received research support from CARRA and Bristol-Myers Squibb. Address correspondence to Dr. Y. Zhao4, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Email: yongdong.zhao@seattlechildrens.org.

University of Washington School of Medicine, Seattle, Washington; Seattle Children’s Hospital, Seattle, Washington, and Janssen Research & Development, LLC, Spring House, Pennsylvania; University of Iowa Carver College of Medicine, Iowa City, Iowa; Seattle Children’s Hospital and Clinical and Translational Research Center, Seattle, Washington, USA. This study is supported by The Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Arthritis Foundation Small Grants program, and the Chronic Recurrent Multifocal Osteomyelitis (CRMO) Research Fund at the University of Iowa. PJF is supported by R01 AR059703 and by the Marjorie K. Lamb Professorship. YZ received research support from CARRA and Bristol-Myers Squibb. Address correspondence to Dr. Y. Zhao4, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Email: yongdong.zhao@seattlechildrens.org.